Failure of pharmacological DVT prophylaxis due to cold chain disruption: a six-month audit from a tertiary surgical ward in Cairo

冷链中断导致药物性深静脉血栓预防失败:开罗一家三级外科病房为期六个月的审计

阅读:1

Abstract

BACKGROUND: Deep vein thrombosis (DVT) remains a major postoperative complication despite routine prophylaxis. This audit investigated an unexpected rise in DVT incidence in a tertiary surgical ward in Cairo, Egypt. METHODS: A six-month retrospective audit (December 2024-June 2025) included 212 adult patients undergoing general surgical procedures. All received enoxaparin prophylaxis. Clinically suspected DVTs were identified using Wells Score criteria and confirmed by duplex Doppler ultrasonography. Cold chain integrity of enoxaparin storage was reviewed in collaboration with pharmacy and biomedical engineering teams. Descriptive and comparative analyses were performed. RESULTS: Eighteen patients (8.5%) were clinically suspected to have DVT within 30 days postoperatively; 14 cases (6.6%) were confirmed by Doppler. Nine occurred during index admission and five during follow-up. Eleven of 14 confirmed cases (78.6%) were temporally linked to a malfunctioning ward refrigerator with storage temperatures exceeding 25 °C. Patients with DVT were more likely to have undergone emergency surgery and less likely to have received mechanical prophylaxis, although these differences were not statistically significant. No major bleeding events were systematically recorded. Patients with DVT were more likely to have undergone emergency surgery and less likely to have received mechanical prophylaxis, although these differences were not statistically significant. By contrast, exposure to enoxaparin from the malfunctioning refrigerator was significantly associated with postoperative DVT (p = 0.002). CONCLUSION: Cold chain failure was strongly associated with prophylaxis failure and is the most plausible contributor, though definitive pharmacological degradation was not confirmed. Infrastructure monitoring and mechanical prophylaxis adherence are essential to effective thromboprophylaxis. A prospective re-audit is scheduled following corrective measures.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。